Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07456436 · ClinicalTrials.gov registry record

Data-Driven Strategies for Patient Engagement About Cancer Clinical Trials

A clinical trial of Malignant Solid Neoplasm and Hematopoietic and Lymphatic System Neoplasm, sponsored by University of Southern California.

Recruiting
Registry status
50
Enrollment target
1
Study location

NCT07456436 is a study of Malignant Solid Neoplasm and Hematopoietic and Lymphatic System Neoplasm that is actively recruiting participants, run by University of Southern California. The registered enrollment target is 50 participants, below the 1,141-participant average among 176 other Malignant Solid Neoplasm trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07456436, a study of Malignant Solid Neoplasm and Hematopoietic and Lymphatic System Neoplasm, is actively recruiting participants, sponsored by University of Southern California.

RECRUITING
Registry status
50 participants
Enrollment target
1
Study location

Study Summary

This study assesses patient awareness and understanding of cancer clinical trials.

Interventions

  • OTHER Non-Interventional Study

Study Locations (1)

California

  • USC / Norris Comprehensive Cancer Center - Los Angeles

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2024-11-26
Est. Completion 2027-11-26

Sponsor

University of Southern California

617 total trials

What the Registry Record Tells You About NCT07456436

The ClinicalTrials.gov registry entry for NCT07456436 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,141-participant average among 176 other Malignant Solid Neoplasm trials with a reported enrollment target (96% lower). The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Malignant Solid Neoplasm appearing as the primary indexed condition, and to 1 intervention - of which Non-Interventional Study is the first listed.

NCT07456436 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT07456436 about?

NCT07456436 is a clinical study titled "Data-Driven Strategies for Patient Engagement About Cancer Clinical Trials". This study assesses patient awareness and understanding of cancer clinical trials.

What is the current status of trial NCT07456436?

This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2024-11-26. Estimated completion is 2027-11-26.

What conditions does trial NCT07456436 study?

This clinical trial studies the following conditions: Malignant Solid Neoplasm, Hematopoietic and Lymphatic System Neoplasm.

What interventions are being tested in trial NCT07456436?

The interventions under investigation include: Non-Interventional Study (OTHER).

Who is sponsoring clinical trial NCT07456436?

This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07456436 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Malignant Solid Neoplasm

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.